A phase II neoadjuvant trial of anastrozole, fulvestrant and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

Endocrine therapy in patients with breast cancer can be limited by the problem of resistance. Preclinical studies suggest that complete blockade of the estrogen receptor (ER) combined with inhibition of the epidermal growth factor receptor (EGFR) can overcome endocrine resistance. We tested this hyp...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Breast Cancer Res Treat
Main Authors: Massarweh, Suleiman, Tham, Yee L, Huang, Jian, Sexton, Krystal, Weiss, Heidi, Tsimelzon, Anna, Bayer, Amanda, Rimawi, Mothaffar, Cai, Wei Yen, Hilsenbeck, Susan, Fuqua, Suzanne, Elledge, Richard
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2011
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477822/
https://ncbi.nlm.nih.gov/pubmed/21792626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1679-8
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla